samedan logo
 
 
spacer
home > epc > spring 2003 > central lab values in an edc environment
PUBLICATIONS
European Pharmaceutical Contractor

Central Lab Values in an EDC Environment

As use increases of e-clinical trial systems for the capture, integration, review and correction of data by the clinical trial industry, more and more interest is geared towards the integration of clinical laboratory values, which can represent up to 70 per cent of all the data in some clinical trials. This article is written from the viewpoint of a former manager of central labs who now works to provide pharmaceutical companies with e-clinical trial technology. I begin by looking at where electronic data capture (EDC) and the central lab industry are today. It is obviously early in the adoption cycle, and the issues that need to be resolved include who controls the lab data and the role of standardisation in bringing dependable solutions, to current concerns that clinical trial managers have about integrating lab data with other clinical data in an EDC environment.

What is an EDC Environment?

There are many ways to define the EDC environment. However, EDC generally refers to electronic data capture of so-called electronic CRFs. The standard model is online web EDC, where the staff at a clinical research site have access to eCRFs through the worldwide web. In the standard model, site personnel transcribe data from paper-source documents to eCRFs that appear as electronic forms on web browsers. They also use the web to review and correct clinical trial data.

The advantages of this model are well known; the main ones being online edit checks, ensuring a clear increase in the accuracy of the data collection process and therefore a decrease in the number of queries and in the time required to resolve them. Other advantages are often mentioned, like the faster availability of trial status information for the company, an improvement in project management, or electronic support for remote data monitoring. However, EDC brings these advantages to life only if the site staff use the website to enter data in a timely fashion. If not, these benefits do not exist.


Read full article >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Valdo Arnera MD, General Manager of PHT Corporation
 
Valdo Arnera MD is General Manager Europe at PHT Corporation. He has over 16 years of experience in the pharmaceutical industry. Starting his career as a clinical pharmacologist in a Ciba-Geigy daughter company, he then founded the first European central clinical laboratory dedicated to clinical trials, SciCor (now Covance central laboratory).

Always passionate about improving the clinical trial process, Valdo joined PHT in 2000 and founded the European affiliate of PHT Corporation in January 2001.


spacer
Valdo Arnera
spacer
spacer
Print this page
Send to a friend
Privacy statement

Industry Events

Line Clearance in Pharmaceutical Packaging & Manufacturing

5 February 2009, Manchester, UK


More info >>

 
News and Press Releases

Lilly Selects ICON to Manage its Clinical Data Management Business Outside the US

18th November 2008
More info >>

 

©2000-2007 Samedan Ltd.
About Us | Register | Login | Site Map | Terms and Conditions | Contact Us |
Add to favourites

Print this page

Send to a friend
Privacy statement